Pourquoi choisir Israël pour la thérapie biologique ?
Accédez à des solutions avancées de thérapie biologique dans des cliniques de confiance .
| Israël | Turquie | Espagne | |
| Thérapie biologique | - | de $5,500 | de $15,000 |
Jour 1 - Arrivée
Jour 2 - Pré-opération
Jour 3 - Préparation à la thérapie biologique
Jour 4 - Thérapie biologique
Jour 5 - Post-opératoire
Semaine 1 - Rééducation
Semaine 2 - Rééducation
Semaine 4 - Rééducation
Veuillez noter que le calendrier et le processus peuvent varier en fonction des problèmes de santé individuels et de la réponse à la thérapie.
Le Dr Sarid est spécialisé en thérapie biologique du cancer au Centre médical Sourasky, avec plus de 15 ans d'expérience en oncologie.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Le Dr Ari Raphael dirige des recherches génomiques révolutionnaires au Sourasky Medical Center, spécialisé dans la thérapie biologique pour les malignités thoraciques.